ArriVent BioPharma Inc. C...

18.14
0.24 (1.34%)
At close: Apr 17, 2025, 3:59 PM
18.14
0.00%
After-hours: Apr 17, 2025, 04:07 PM EDT

ArriVent BioPharma Common Stock Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022
Period Ending Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022
-80.49M -81.05M -74.89M -74.58M -69.33M -58.58M -55.95M -41.73M -36.91M -26.46M -14.7M -7.35M
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
3.21M 2.58M 1.93M 1.35M 895K 689K 585K 491K 424K 311K 198K 99K
7.82M 9.09M 7.54M 14.25M 11.22M -26K -1.46M -12.49M -9.95M -4.37M -3.91M -1.95M
999K 1.02M 3.47M -31K -484K -414K -666K 3.13M 2.88M 2.78M 586K 293K
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
7.07M 9.5M 4.89M 15.63M 12.6M 1.08M 1.87M -12.85M -9.93M -4.37M -3.91M -1.95M
-70.21M -68.97M -68.07M -57.59M -55.84M -56.82M -51.3M -51.6M -43.63M -27.74M -17.82M -8.91M
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
-194.16M n/a n/a -25M -25M -25M -25M n/a n/a n/a n/a n/a
n/a 25M 25M 25M 25M n/a n/a n/a n/a n/a n/a n/a
1.7M 25M 25M 25M 25M n/a n/a n/a n/a n/a n/a n/a
-192.47M 25M 25M n/a n/a -25M -25M n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
631K -481K -2.04M -2.08M -2.06M -988K 45K 30.04M 60.02M 60M 60M 30M
186.58M 185.47M 183.91M 183.52M 42.86M 153.64M 154.67M 184.69M 169.72M 60M 60M 30M
-76.1M 141.5M 140.84M 125.93M -12.98M 71.82M 78.37M 191.46M 163.37M 69.54M 79.46M n/a
-70.21M -68.97M -68.07M -57.59M -55.84M -56.82M -51.3M -51.6M -43.63M -27.74M -17.82M -8.91M